Discovery of a Novel Series of Quinolone and Naphthyridine Derivatives as Potential Topoisomerase I Inhibitors by Scaffold Modification
Authors:
- Qi-Dong YouQYQi-Dong You
- Chiung-Hua HuangCHChiung-Hua Huang
- Tsai-Kun LiTLTsai-Kun Li
- Ji-Wang ChernJCJi-Wang Chern
- 28 August 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (18) , 5649-5661
Abstract
A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold modification strategy. Thirty-one new compounds were synthesized and evaluated for anticell proliferation activity. The most potent compound 26 presented a significant inhibitory effect on Top I, leading to Top I-mediated cleavage and influences on Top I expression at the cellular level. Moreover, 26 was proved to induce cell death via apoptosis and accelerated DNA strand breaks without significant alteration in cell cycle populations. All of the experimental results herein indicated that 26 could interact with DNA−Top I complex and induce cancer cell apoptosis to produce antitumor effects. The in vivo evaluation of 26 on the growth of HT-29 tumor xenografts in nude mice suggested its therapeutic potential for further development.Keywords
This publication has 19 references indexed in Scilit:
- A Systematic Study of Nitrated Indenoisoquinolines Reveals a Potent Topoisomerase I InhibitorJournal of Medicinal Chemistry, 2006
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Total Synthesis and Biological Evaluation of 22-HydroxyacuminatineJournal of Medicinal Chemistry, 2006
- Camptothecin: current perspectivesBioorganic & Medicinal Chemistry, 2004
- Design, Synthesis, and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors and Indenoisoquinoline−Camptothecin HybridsJournal of Medicinal Chemistry, 2003
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some AnaloguesJournal of Pharmaceutical Sciences, 1992
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989
- On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexBiochemistry, 1989
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966